Akèy › Maladi fwa steatotik › Texas › Grand Prairie
Etid klinik pou Maladi fwa steatotik nan Grand Prairie, TX
5 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Grand Prairie (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, DeSoto · 14 mi lwen
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, DeSoto · 14 mi lwen
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Ap rekriteFaz 3
- Epic Medical Research - DeSoto, DeSoto · 14 mi lwen
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Ap rekriteFaz 3
- GSK Investigational Site, DeSoto · 14 mi lwen
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Ap rekriteFaz 3
- GSK Investigational Site, DeSoto · 14 mi lwen
Etid Maladi fwa steatotik nan lòt vil
- San Antonio, TX17 etid
- New York City, NY16 etid
- Miami, FL16 etid
- San Diego, CA14 etid
- Austin, TX13 etid
- Houston, TX13 etid
- Richmond, VA12 etid
- Tucson, AZ10 etid
- Chandler, AZ10 etid
- St. Louis, MO9 etid
- Hialeah, FL9 etid
- Dallas, TX9 etid
Lòt etid nan Grand Prairie
- Obèsite13 etid
- Sipwa11 etid
- Twoub depresif majè11 etid
- Skizofreni8 etid
- Depresyon8 etid
- Ensifizyans kadyak4 etid
- BPCO3 etid
- Migrèn3 etid
- Dyabèt Tip 23 etid
- Twoub psikotik3 etid
- Twoub Imè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.